Andrew J. Einhorn is CFO at Edge Therapeutics, Inc. (EDGE). They have made 1 open-market trade across 1 company since 2015, most recently 2025-12-23.
CIK 0001560685
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $495K since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EDGE | BUY | 2015-10-06 | 2015-10-08 | $11.00 | $495K | -3.7% | +0.9% | +12.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.